BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34724019)

  • 21. Imaging of amyloid burden and distribution in cerebral amyloid angiopathy.
    Johnson KA; Gregas M; Becker JA; Kinnecom C; Salat DH; Moran EK; Smith EE; Rosand J; Rentz DM; Klunk WE; Mathis CA; Price JC; Dekosky ST; Fischman AJ; Greenberg SM
    Ann Neurol; 2007 Sep; 62(3):229-34. PubMed ID: 17683091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cerebral Amyloid Angiopathy-Related Inflammation.
    Renard D; Wacongne A; Ayrignac X; Charif M; Fourcade G; Azakri S; Le Floch A; Bouly S; Marelli C; Arquizan C; Hirtz C; Gabelle A; Thouvenot E; Lehmann S
    J Alzheimers Dis; 2016; 50(3):759-764. PubMed ID: 26757185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical application of serological Alzheimer's disease diagnosis using a highly sensitive biosensor with hydrogel-enhanced dielectrophoretic force.
    Kim HJ; Choi W; San Lee J; Choi J; Choi N; Hwang KS
    Biosens Bioelectron; 2022 Jan; 195():113668. PubMed ID: 34583104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma β-amyloid levels in cerebral amyloid angiopathy-associated hemorrhagic stroke.
    Hernandez-Guillamon M; Delgado P; Penalba A; Rodriguez-Luna D; Molina CA; Rovira A; Alvarez-Sabin J; Boada M; Montaner J
    Neurodegener Dis; 2012; 10(1-4):320-3. PubMed ID: 22261638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Amyloid PET in Diagnosing Possible Transmissible Cerebral Amyloid Angiopathy in Young Adults with a History of Neurosurgery: A Case Series.
    Michiels L; Van Weehaeghe D; Vandenberghe R; Demeestere J; Van Laere K; Lemmens R
    Cerebrovasc Dis; 2021; 50(3):356-360. PubMed ID: 33744891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct deposition of amyloid-β species in brains with Alzheimer's disease pathology visualized with MALDI imaging mass spectrometry.
    Kakuda N; Miyasaka T; Iwasaki N; Nirasawa T; Wada-Kakuda S; Takahashi-Fujigasaki J; Murayama S; Ihara Y; Ikegawa M
    Acta Neuropathol Commun; 2017 Oct; 5(1):73. PubMed ID: 29037261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Core cerebrospinal fluid biomarker profile in cerebral amyloid angiopathy: A meta-analysis.
    Charidimou A; Friedrich JO; Greenberg SM; Viswanathan A
    Neurology; 2018 Feb; 90(9):e754-e762. PubMed ID: 29386280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.
    de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM
    J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resorufin analogs preferentially bind cerebrovascular amyloid: potential use as imaging ligands for cerebral amyloid angiopathy.
    Han BH; Zhou ML; Vellimana AK; Milner E; Kim DH; Greenberg JK; Chu W; Mach RH; Zipfel GJ
    Mol Neurodegener; 2011 Dec; 6():86. PubMed ID: 22192811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer's disease.
    Hondius DC; Eigenhuis KN; Morrema THJ; van der Schors RC; van Nierop P; Bugiani M; Li KW; Hoozemans JJM; Smit AB; Rozemuller AJM
    Acta Neuropathol Commun; 2018 Jun; 6(1):46. PubMed ID: 29860944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensitivity and Specificity of the Boston Criteria Version 2.0 for the Diagnosis of Cerebral Amyloid Angiopathy in a Community-Based Sample.
    Zanon Zotin MC; Makkinejad N; Schneider JA; Arfanakis K; Charidimou A; Greenberg SM; van Veluw SJ
    Neurology; 2024 Jan; 102(1):e207940. PubMed ID: 38165367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebral Amyloid Angiopathy-Related Microbleeds Correlate with Glucose Metabolism and Brain Volume in Alzheimer's Disease.
    Samuraki M; Matsunari I; Yoshita M; Shima K; Noguchi-Shinohara M; Hamaguchi T; Ono K; Yamada M
    J Alzheimers Dis; 2015; 48(2):517-28. PubMed ID: 26402015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral Amyloid Angiopathy-Related Microbleeds and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease.
    Noguchi-Shinohara M; Komatsu J; Samuraki M; Matsunari I; Ikeda T; Sakai K; Hamaguchi T; Ono K; Nakamura H; Yamada M
    J Alzheimers Dis; 2017; 55(3):905-913. PubMed ID: 27802236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atrophy patterns in cerebral amyloid angiopathy with and without cortical superficial siderosis.
    Kim J; Na HK; Shin JH; Kim HJ; Seo SW; Seong JK; Na DL
    Neurology; 2018 May; 90(20):e1751-e1758. PubMed ID: 29678935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of cerebral amyloid angiopathy define histopathological phenotypes in Alzheimer's disease.
    Allen N; Robinson AC; Snowden J; Davidson YS; Mann DM
    Neuropathol Appl Neurobiol; 2014 Feb; 40(2):136-48. PubMed ID: 23808763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cortical Thickness and Its Association with Clinical Cognitive and Neuroimaging Markers in Cerebral Amyloid Angiopathy.
    Subotic A; McCreary CR; Saad F; Nguyen A; Alvarez-Veronesi A; Zwiers AM; Charlton A; Beaudin AE; Ismail Z; Pike GB; Smith EE
    J Alzheimers Dis; 2021; 81(4):1663-1671. PubMed ID: 33998545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways.
    Greenberg SM; Bacskai BJ; Hernandez-Guillamon M; Pruzin J; Sperling R; van Veluw SJ
    Nat Rev Neurol; 2020 Jan; 16(1):30-42. PubMed ID: 31827267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-amyloid pathology in human brain microvessel extracts from the parietal cortex: relation with cerebral amyloid angiopathy and Alzheimer's disease.
    Bourassa P; Tremblay C; Schneider JA; Bennett DA; Calon F
    Acta Neuropathol; 2019 May; 137(5):801-823. PubMed ID: 30729296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CSF biomarkers and amyloid PET: concordance and diagnostic accuracy in a MCI cohort.
    Spallazzi M; Barocco F; Michelini G; Immovilli P; Taga A; Morelli N; Ruffini L; Caffarra P
    Acta Neurol Belg; 2019 Sep; 119(3):445-452. PubMed ID: 30847669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Florbetapir imaging in cerebral amyloid angiopathy-related hemorrhages.
    Raposo N; Planton M; Péran P; Payoux P; Bonneville F; Lyoubi A; Albucher JF; Acket B; Salabert AS; Olivot JM; Hitzel A; Chollet F; Pariente J
    Neurology; 2017 Aug; 89(7):697-704. PubMed ID: 28724587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.